Key result
Valve-sparing operations are linked to ~42% fewer mid-term aortic valve reoperations versus biologic root replacement.
Why the study?
Does a valve-sparing operation compared to root replacement with a biologic composite conduit improve outcomes in patients with aortic root aneurysm?
Cohort (n=749)
Yes
Does a valve-sparing operation compared to root replacement with a biologic composite conduit improve outcomes in patients with aortic root aneurysm?
Answers are grounded in this paper and cite their sources.
Both valve-sparing operations and root replacement with a biologic composite conduit provide excellent outcomes for aortic root aneurysm, though biologic conduits are associated with a higher mid-term risk of reoperation.
OBJECTIVES: Valve-sparing operations and root replacement with a biologic composite conduit are viable options in aortic root aneurysm. This study was conceived to compare the early and mid-term results of these 2 procedures. METHODS: From September 2002 to November 2015, 749 consecutive patients underwent either a valve-sparing operation or a root replacement with a biologic composite conduit at 2 institutions. Propensity score matching was used to compare similar cohorts of patients in the overall population and in the ≤ 55 and ≥ 65-year age groups. RESULTS: Overall operative mortality was 0.4%, mean age 57.4 ± 14.3 years, 84.6% were male. Individuals in the biologic composite conduit group were older and had worse preoperative risk profiles [chronic pulmonary disease (5.5% vs 0.9%; P = 0.001), diabetes (6.4% vs 1.5%; P = 0.001) and NYHA > 2 (25.2% vs 5.2%; P < 0.001)]. Mean follow-up was 27.5 ± 28.4 months. In the unmatched population, there was no difference in in-hospital deaths (0 in the valve-sparing versus 3 in the biologic composite conduit group; P = 0.12). These findings were confirmed in the propensity-matched populations. During follow-up, more patients in the biologic composite conduit group underwent reoperation on the aortic valve (2.6% vs 1.5%; P = 0.026) resulting in a freedom from reoperation of 97.4% vs 98.5%, respectively. Separate analysis for patients stratified by age revealed no difference in outcomes. CONCLUSIONS: In case of aortic root aneurysm, both valve-sparing operations and root replacement with a biologic composite conduit provide excellent outcomes. However, at mid-term follow-up the use of biologic composite conduit is associated with a higher risk of reoperation.
No takes yet. Share an insight, caveat, or question.
Gaudino et al. (2017) conducted a cohort in Aortic root aneurysm (n=749). Valve-sparing operation vs. Root replacement with a biologic composite conduit was evaluated on Reoperation on the aortic valve (p=0.026). Valve-sparing operations for aortic root aneurysm were associated with a lower risk of mid-term aortic valve reoperation compared to biologic composite conduit root replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: